A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria
A Randomized Doubleblind Placebo Controlled Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria
Sponsor: Steno Diabetes Center Copenhagen
A PHASE4 clinical study on Blood Pressure and Diabetes Mellitus, this trial is ongoing. The trial is conducted by Steno Diabetes Center Copenhagen and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jun 2019 [monthly]
Unknown Status PHASE4
First recorded
Mar 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Steno Diabetes Center Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.